| Time | Topic | Speaker |
|---|---|---|
| Colloquium: | Diagnostics, Disease and Implications | Fairchild Auditorium |
| 1:00-1:15 p.m. | Introduction | Paul Berg Director, Beckman Center |
| 1:15-1:55 p.m. | "Genome Impact on Drug Development" | Thomas Caskey Senior Vice-President, Research Merck Research Laboratories |
| 2:00-2:40 p.m. | "The Evolution of Commercial Genetic Diagnostic Services: Risks, Regulation and Responsibility" | George Poste President, Research and Development SmithKline Beecham Pharmaceuticals |
| 2:45-3:05 p.m. | Break | |
| 3:05-3:45 p.m. | "Previewing the Future-With No Rewind Button or Changing Channels" | Nancy Wexler Professor of Neuropsychology Columbia University |
| 4:00-4:40 p.m. | "From Basic Research to Standard of Care-Pitfalls in the Diffusion of Genetic Tests" | Neil Holtzman Director, Genetics and Public Policy Studies Johns Hopkins Medical Institutions |
| Time | Topic | Speaker |
|---|---|---|
| Public Forum: | Ethical Dilemmas | Annenberg Auditorium Cummings Art Building |
| 7:30-7:45 p.m. | Introduction | David Singer President and CEO Affymetrix |
| 7:45-9:15 p.m. | Panel Discussion | Moderator: Donald Kennedy President Emeritus Stanford University |
For more information contact Chris Scott at (415) 723-7184
Paul Berg, Ph.D., is Cahill Professor in Cancer Research and Director of the Beckman Center For Molecular and Genetic Medicine at Stanford University. He received the Nobel Prize in Chemistry in 1980 for his work on recombinant DNA. He is a member of the National Academy of Sciences, a fellow of the Royal Society and past Chairman of the Advisory Committee of the Human Genome Project.
Jerry Bishop is the Deputy News Editor For the Wall Street Journal, New York. He has received awards For his science reporting from the American Heart Association, the American Association for the Advancement of Science and the National Association of Science Writers, among others. He co-authored Genome, a book about biogenetics.
Thomas Caskey, M.D., EA.C.R, is the Senior Vice President, Research at Merck Research Laboratories and Adjunct Professor in the Department of Molecular and Human Genetics, Medicine, Biochemistry and Cell Biology at Baylor College of Medicine. He is a member of the National Academy of Sciences and serves on two government advisory panels on mapping the human genome.
David Cox, M.D., Ph.D., is Professor of Genetics and Pediatrics and Co-Director of the Human Genome Center, Stanford University. His research centers on high- resolution maps of mammalian chromosomes. He is past Chairman of the Human Genome Committee and a member of the Ethical, Legal and Social Implications Working Group For the National Center for Human Genome Research.
Dave Frohnmayer, J.D., is President of the Unversity of Oregon. He has been Oregon's Attorney General and has served three terms in the Oregon House of Representatives. He and his wife, Lynn, are Founders of the Fanconi Anemia Research Fund, Inc., which funds genetic research For this disease. He is one of the founding directors of the National Marrow Donor Program.
Henry (Hank) Greely, J.D., is Professor of Law at StanFord University. A past clerk on the United State Court of Appeals and the United States Supreme Court, he serves on the Health Benefits Advisory Council to the California Public Employee Retirement System and chairs the ethics subcommittee on the North American Committee of the Human Genome Diversity Project
Dean Hamer, Ph.D., is Chief, Section on Gene Structure and Regulation in the Laboratory of Biochemistry of the National Cancer Institute. His research has focused on drug and vaccine production and gene regulation. Most recently, he has discovered a genetic link to male sexual orientation. He is the co-author of the book The Science of Desire.
Neil Hoitzman, M.D. is Professor of Pediatrics with joint appointments in Health Policy and Epidemiology at Johns Hopkins University. He was a policy analyst for the Congress Office of Technology Assessment and former Director of the Hereditary Disease Disorders Program of the State of Maryland. He is the co-author of Assessing Genetic Risks which explores policy issues raised by the Human Genome Project.
Donald Kennedy, Ph.D. is Bing Professor of Environmental &ience and President emeritus of Stanford University. He has served as a Senior Consultant in the Office of &ience and Technology Policy, Executive Office of the President and Commissioner of the Food and Drug Administration. He is a member of the National Academy of Sciences, and helps direct the Environmental Studies Program at Stanford.
Barbara Koenig, Ph.D. is Executive Director and Senior Research Scholar at Stanford University Center For Biomedical Ethics. Her research focuses on a number of projects on clinical topics of relevance to bioethics. She has served on the clinical ethics committees of several hospitals and long-term care facilities.
George Poste, D.Sc., Ph.D., is President, Research and Development, of SmithKline Beecham Pharmaceuticals. He is a fellow in the Royal College of Veterinary Surgeons and the Royal College of Pathologists, London. He has served on Government committees for the NIH, the Office of Technology Assessment and the Departments of State, Commerce and Defense.
Nancy Wexler, Ph.D. is Higgins Professor of Neuropsychology in the Departments of Neurology and Psychiatry, Columbia University. Her research includes the isolation of the gene for Huntington's Disease. She is a member of the Advisory Committee to the Human Genome Center at Lawrence Berkeley Laboratories and is Chair of the Ethical, Legal and Social Implications Working Group for the National Center for Genome Research.
Ernie Young, Ph.D., is the Co-Director of the Center for Biomedical Ethics and Clinical Professor of Ethics in the Departments of Medicine and Pediatrics, Stanford University. He is co-author of A Time to be Born, A Time to Die: Ethics and Conflicts in An intensive Care Nursery and author of Alpha and Omega: Ethics at the Frontiers of Life and Death.